Cognition Therapeutics regains Nasdaq minimum bid price compliance

COGNITION THERAPEUTICS INC

On Aug 26, 2025, Nasdaq confirmed Cognition Therapeutics regained compliance with the $1.00 minimum bid price rule.
Stock had closed above $1.00 for more than 10 consecutive trading days as of Aug 25, 2025.
Company previously received deficiency notice on Sep 12, 2024 for bid price below $1.00 for 30 days.
Compliance removes immediate delisting risk under Nasdaq Listing Rule 5450(a)(1).

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.